Refine by
Ophthalmic Articles & Analysis: Older
20 articles found
Antibody drugs are a kind of drugs that treat diseases through artificially synthesized antibodies, achieving therapeutic purposes by specifically binding with target molecules. Common types of antibody drugs include monoclonal antibodies, artificially synthesized antibody fragments, immunotoxins, antibody-drug conjugates, etc. Antibody drugs have shown remarkable therapeutic effects in the ...
Human corneal epithelial cells play a vital role in maintaining the health and function of the cornea, the transparent front part of the eye. This layer of cells acts as a protective barrier against environmental insults, pathogens, and mechanical injury. Given their crucial functions, understanding these cells is essential for advancements in ophthalmology and regenerative medicine. The corneal ...
HCEC-12 is a well-established human corneal epithelial cell line derived from human corneal tissue. It plays a crucial role in ocular research, particularly for studies related to corneal physiology, wound healing, and the pathogenesis of various ocular diseases. This article delves into the characteristics, applications, and significance of the HCEC-12 cell line in biological and medical ...
Antibody drugs are a type of drugs that treat diseases through artificially synthesized antibodies, which bind specifically to target molecules for therapeutic purposes. Common types of antibody drugs include monoclonal antibodies, artificially synthesized antibody fragments, immunotoxins, and antibody-drug conjugates, etc. Antibody drugs have shown significant therapeutic effects in the ...
What are Antimicrobial Peptides? Antimicrobial peptides (AMPs) are naturally occurring peptide molecules found in various organisms, including humans, animals, plants, and microorganisms. These peptides play a crucial role in the innate immune system's defense against microbial infections, exhibiting antimicrobial properties that can inhibit the growth or kill bacteria, fungi, viruses, and even ...
Optics and medical devices have a long history and partnership. Since the invention of the microscope in the late 1500s to mid-1600s, the interest and desire to “see” into the human body to diagnose illness and subsequently repair it has only intensified. Optics in modern medical devices fall into two categories: those used for diagnosis of illness, and those which are therapeutic or ...
Choose from over 3,000 configurations to find the perfect lens for each patient With a portfolio including the Eden and Lucidis premium IOLs, Swiss Advanced Vision (SAV-IOL) is already known for redrawing innovation boundaries in the IOL landscape. Now, the company is launching a system that brings customizable medicine to the world of cataract surgery. SAV-IOL’s unique offering comprises ...
Silence Therapeutics, a pioneer in the development of novel small interfering RNA (siRNA) therapeutics, and Mallinckrodt plc, a global biopharmaceutical company, announced the submission of a clinical trial application (CTA) for SLN501, a siRNA therapy targeting the complement C3 protein, on March 23, 2022. Silence will receive a $3 million milestone payment from Mallinckrodt as a result of the ...
The challenge The Pierre Oudot Hospital was constructed in 2011 and took up the challenge of building a “full digital” establishment to meet the requirements of a connected and communicating hospital. By implementing the PACS and phasing out radiological films, the hospital has created the conditions for the multimedia environment in the operating room. All the rooms are ...
Founded in 2014 in California, AXIM® Biotechnologies, Inc. is a vertically integrated research and development company focused on improving the landscape for diagnosis of ophthalmological conditions such as Dry Eye Disease (DED) through rapid diagnostic tests. Additionally, it owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect ...
ByIUL S.A.
Aramis Biosciences announced that the first patient has been dosed in its phase 2 proof of concept clinical trial evaluating A197, a novel, first-in-class, topical immunomodulatory agent for the treatment of dry eye disease. “This is an important milestone for Aramis Biosciences and a hopeful moment for dry eye patients given the suboptimal efficacy and tolerability limitations commonly ...
Although post-mortem brains have been frequently reported as the "gold standard" in transcriptomic research for ND and neuropsychiatric abnormalities, the main sources has been mRNA separated from transgenic animal models and, more lately, patient-derived cell lines. However, despite their promise, transcriptome studies are difficult due to the obvious difficulties in obtaining brain tissue and ...
When automated dark adaptometry was first commercialized, many of us had more questions than answers with regard to using this information for detecting AMD and monitoring disease progression. But with more than seven years of practical in-office experience performing dark adaptation testing on thousands of patients, the tables have turned. This technology offers a safety net for ...
Twelve years ago Jody started getting unexplained pain, swelling and redness in her eyes after having her first child. Shortly after, she was diagnosed with Scleritis¹, a serious eye disease that is often associated with an underlying autoimmune disorder. Fast forward to today, Jody has started taking weekly injections to ease her symptoms. We sat down with Jody to hear ...
The EnviroTower system allowed operator to cycle up the water system saving over 12% water and eliminated need of hazardous chemicals by over 92%. Michael E. DeBakey veterans Affairs Medical Center (MEDVAMC) is a care facility affiliated with the United States Department of Veterans Affairs in the Texas Medical Center m Houston, Texas. United States. It is operated by the United States ...
Medical care delivery has gone through remarkable changes in the previous decade. In the last five to 10 years, medical services’ digitization has quickened dramatically because of inventive government strategies, changes in customer inclinations, a flood of funding, a developing number of computerized wellbeing business people, and proceeded with ventures by industry occupants. The ...
NESS ZIONA, Israel, Feb. 5, 2020 /PRNewswire/ -- EyeYon Medical (https://eye-yon.com/) is a start-up company developing a variety of ophthalmic products for vision-threatening conditions. EyeYon's new product, now on an accelerated path as a Breakthrough Device, is an Artificial Endothelial Layer - EndoArt® - a polymer film implant, attached to the posterior corneal surface, to treat chronic ...
Mojo Vision's smart contacts put text in my eye and let me see in the dark. The company is aiming for even more than that. There aren't many meetings in Las Vegas during CES that still make my jaw drop. The few I can think of mostly involved Oculus. I had no idea what a company I've never met with before, called Mojo Vision, was going to show me. I knew they made very, very small displays. I ...
What is 19C27? Description LZQ is an OEM factory for all kinds of medical tools, such as Profile Drill P144, Dental Milling Bur/ Zirconia Bur P245, High Precision Fittings P76, Abutment/Transfer P25, ect. We can produce a whole kit of tools for customers' surgical cases. Product Details A complete line of Ophthalmic Surgical Knives includes Stab Knife, Slit Knife and Clear Cornea Knife, ...
The first stand-alone prosthetic iris has received regulatory approval in the United States. CustomFlex Artificial Iris (HumanOptics) is a flexible silicone device indicated for adults and children with congenital aniridia or iris defects due to albinism, traumatic injury or surgical removal. “Today’s approval of the first artificial iris provides a novel method to treat iris ...